CTG18.1 is a highly polymorphic and unstable CTG repeat within an intron of the SEF2-1 gene. We tested the CTG18.1 repeat length in affective disorder, schizophrenia, and nonspecific ataxia; these diseases all have shown clinical evidence for anticipation. There was no difference in the allele frequencies comparing the controls and disease groups. The most common allele contains 11 CAGs (35%) followed by alleles with 14-17 CAGs (35%). There was no difference in the distribution of the alleles in the cases vs controls for ataxia (P = 0.11), affective disorders (P = 0.21), or schizophrenia (P = 0.26). The frequency of unstable CTG18.1 alleles was approximately 3% in a population of N. European descent and is not related to the phenotypes tested. Molecular Psychiatry (2000) 5, 439-442. 
The identification of genes containing unstable trinucleotide repeats which can be expanded to cause illness has provided a molecular explanation for the phenomenon of genetic anticipation-the intergenerational increase in disease severity or decrease in age of onset. The expansion ranges from small increases over the normal size range 1 to several hundred-fold increases in the repeat length. 2 The association of expanded trinucleotide repeats and anticipation has led to the hypothesis that genes containing unstable repeats may be implicated in other disorders with apparent anticipation.
Anticipation has been described in bipolar disorder [3] [4] [5] [6] [7] and schizophrenia. 8, 9 Further, the repeat expansion detection (RED) method has identified subjects with larger RED products of (CAG) n in bipolar disorder or schizophrenia compared to controls, with the implication that a locus with an enlarged (CAG) repeat is etiologically associated with the illness. [10] [11] [12] [13] [14] However, not all studies have found this. 15, 16 We recently described a highly polymorphic (observed heterozygozity 84%) and unstable CAG repeat locus (CTG18.1) in the third intron of the SEF2-1 gene. 17 The frequency of unstable and enlarged (CAG) n alleles was approximately 3% and there was apparently no association of enlarged alleles with disease in 48 pedigrees with bipolar disorder. The CTG18.1 locus is of particular interest for bipolar disorder as linkage has been reported in the immediate genetic vicinity. 18 The CTG18.1 locus was recently studied in 60 bipolar subjects and 114 controls (all Swedish) as well as 14 Swedish bipolar pedigrees. 10 Of 60 bipolar subjects eight had RED products Ͼ120 nucleotides (40 CAGs) while six of 108 control subjects had RED products Ͼ120 nucleotides determined to be at the CTG18.1 locus. They studied 14 BP pedigrees, 12 of whom had subjects with enlarged CTG18.1 alleles. In analyses of the 12 pedigrees, 10 of 53 affected and 10 of 113 unaffected offspring had enlarged CTG18.1 alleles. In this relatively small sample this was interpreted as the presence of enlarged CAG alleles in the bipolar group. There was no association between enlarged CTG18.1 alleles and bipolar disorder in a Belgian sample consisting of 51 BP cases and 99 controls. 19 In a collaborative effort to determine the frequency of the CTG18.1 alleles in the general population and to test the hypothesis that enlarged alleles confer susceptibility to neuropsychiatric disease, we have now studied several populations including cases of bipolar disorder, schizophrenia, and ataxia as well as controls. The population was composed of subjects of European ancestry and included subjects from Eastern Canada and USA, Belgium, Germany, and Croatia. We compared the frequencies of alleles among the control groups and compared the frequencies among cases and controls. A subset of the study population included data from triads consisting of an affected subject and parents and a family-based association was performed using the TDT. The total sample consisted of: (1) Belgian sample: 88 BPI, 49 UP, and 75 controls; (2) Croatian sample: 40 BPI, 35 UP, and 66 controls; (3) JHU sample: 54 BPI, 57 unaffected family members for controls; (4) NIMH Bipolar Genetics Initiative-Bipolar Collaborative sample: 44 BPI, 56 unaffected family members for controls; (5) CEPH: 55 unrelated subjects for JHU additional controls; (6) schizophrenia sample (JV): 96 schizophrenics, and 96 controls; (7) ataxia of undiagnosed origin (OR): 212 subjects and 239 controls over age 80. The results of a subset of the Belgian, 19 Hopkins 17 and schizophrenic samples 16 have been previously reported. There was no difference in the distribution of the alleles among the control groups (all of European descent). The allele frequencies for the combined control populations and affected populations are shown in Table 1 . The most common allele in the controls contains 11 CAGs (35%) followed by the alleles with 14-17 CAGs (35%). These five alleles accounted for approximately 70% of the observed alleles in both the cases and controls. There was no difference in the distribution of the alleles in the cases vs controls for ataxia (P = 0.11), affective disorders (P = 0.21), or schizophrenia (P = 0.26) (see also Vincent et al 16 ) . A subset of the JHU sample was previously reported 17 to have no association between enlarged alleles and BP dis- order, and likewise with a subset of the Belgian sample. 19 Comparison of allele frequencies per site or diagnosis did not indicate differences.
There was no difference in the distribution of alleles between cases and controls in either binning method. The transmission disequilibrium test (TDT) analysis of 98 independent bipolar triads was negative ( Figure 1) ; no allele was preferentially transmitted to affected offspring with bipolar disorder. It is readily appreciated from Figure 1 that there appears to be random allele transmission or nontransmission to the affected offspring. The data are shown for bipolar disorder (including BPI, BPII, and schizoaffective disordermanic). Analyses including recurrent unipolar depressive disorder were also negative (data not shown).
The allele frequencies we find in this study of individuals derived from populations of European descent are similar to those previously published for similar population groups. 17 The most common allele is the (CAG) 11 , which with (CAG) [14] [15] [16] [17] accounts for over 70% of alleles. The frequency of enlarged alleles (ϾCAG 40 ) is approximately 3% of the alleles, again comparable to previous studies. 17 The distributions of the alleles in the different control populations (all of European descent) did not differ significantly nor was there any difference in the distributions of alleles in the groups of subjects with affective disorder, schizophrenia, or ataxia of unknown origin. Family-based association studies using the TDT did not reveal preferential distribution of any of the alleles.
These findings do not support those of Linblad et al 10 who reported a weak association with enlarged alleles at the CTG18.1 locus in a sample of bipolar disorder. Their sample was relatively small. Analysis of the 60 BP subjects and 114 controls suggested that there was a trend towards enlarged CTG18.1 alleles in the BP subjects (P = 0.07), however with the Yates correction (for small cell size) the results are less convincing (P = 0.17). Their analysis of 12 pedigrees that showed enlarged CTG18.1 alleles suggested that there was evidence of enlarged (Ͼ40 CAGs) in affected offspring
Molecular Psychiatry compared to unaffected offspring ( 2 = 4.24; P = 0.039). However, with the Yates correction applied to the data the results are not significant ( 2 = 3.24; P = 0.071). The present study examined a much larger population of subjects with affective disorder (total 591 subjects with bipolar or unipolar disorder) including data from 98 bipolar triads. Consistent with the findings of Verheyen et al, 19 there was no evidence of an association with enlarged alleles at the CTG18.1 locus and affective disorder. Analysis of the bipolar or unipolar disorder separately did not affect the results.
Is there an association between unstable CAG repeat loci and bipolar disorder and schizophrenia? Previous studies using the RED technique are difficult to interpret since CTG18.1 and ERDA1 account for a large portion of the RED products. 10, 19, 21 There is some evidence for the involvement of ERDA1 in bipolar disorder. Verheyen et al 19 reported a significantly larger proportion of bipolar patients carrying one or two ERDA1 alleles Ͼ40 repeats with a negative correlation between age of onset and CAG/CTG length in the offspring of eight BP pedigrees. Vincent et al 22 reported evidence of increased repeat size at ERDA1 from parent to offspring in one family with schizoaffective disorder and childhood onset of depression. Lindblad et al 10 found no evidence that ERDA1 is involved in bipolar disorder. There are no data to implicate the CTG18.1 repeat within the SEF2-1b gene, and the current study indicates that CTG18.1 is unlikely to make a substantial contribution to vulnerability to these disorders, though a minor contribution can not be ruled out.
Methods

Sample ascertainment
At the Johns Hopkins University (JHU), families with multiple affected members with bipolar disorder were ascertained as part of a genetic linkage study; a subset of the bipolar pedigrees ascertained through the NIMH Genetics Initiative for Bipolar disorder were also included. 18, 23 Clinical evaluation was performed using either the schedule for affective disorders and schizophrenia-lifetime version (SADS-L) 24 or the diagnostic interview for genetics studies (DIGS). 25 Both methods generate research diagnostic criteria (RDC). 26 Inter-rater reliability was established at JHU in test-retest diagnosis using the same instrument. 18 At the remaining centers (Belgium, Germany, Yugoslavia, Canada), cases were ascertained from treatment clinics and control subjects were drawn from the same populationmatched for age and sex. Psychiatric diagnoses were generated using either the SADS-L or the DIGS; ataxia cases were diagnosed by neurological exam. No crosscenter reliability diagnostic exercises were performed. Control subjects at JHU were drawn from the CEPH population (Amish pedigree 110 was not included) as well as from the unaffected lineage of the linkage pedigrees. Genotyping was performed by PCR across the CAG repeat of the CTG 18.1 locus as previously described.
Statistical analysis
Statistical analysis was performed using a 2 analysis comparing the frequency of the alleles in the cases compared to the controls. The cases and controls from each group of investigators were first analyzed separately, the data from the bipolar investigators were subsequently combined and analyzed as a group. Separate analyses were performed for bipolar and unipolar (depressive) disorder as well as a combined analysis. The allele sizes were collapsed in two ways. The first classification roughly follows the observed clustering of alleles graphically. In the first classification the alleles were grouped at: (1) less than or equal to 13 CAG triplets; (2) greater than 14 and less than or equal to 35 CAG triplets; (3) greater than 35 CAG triplets. The second classification was selected to replicate the findings of Lindblad et al. 10 The alleles were split into two groups: (1) less than 40 CAG triplets; and (2) 40 or more CAG triplets. Binning of multiple alleles has been shown to increase the power of the association analysis. 27 In the 124 bipolar pedigrees from the linkage study, a transmission disequilibrium test (TDT) was performed using the TDTEX package of SAGE 20 to determine if a particular allele was preferentially transmitted to affected offspring.
